Denali Therapeutics Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for DNLI, updated each market day.
DNLI AI Sentiment
AI predicts Denali Therapeutics Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Denali Therapeutics Inc. Common Stock
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Sector
Exchange
Market Cap
$3,217,728,222
Cap Tier
Employees
507
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
Dec. 8, 2017
DNLI Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DNLI Volatility
Denali Therapeutics Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
